You are here: Home Research Cell Biology & Immunology Matt Mulvey, Ph.D.
Document Actions

Matt Mulvey, Ph.D.

last modified 2008-07-08 14:57 — by u0189572

Associate Professor

Scholarly Emphasis: Bacterial Pathogenesis
Matt Mulvey, Ph.D.

Matthew Mulvey, Ph.D

Contact Info

Email Address: Matthew.Mulvey [at] path.utah.edu

Office Phone Number: 801-581-5967

Location: 2520 Emma Eccles Jones Medical Research Building

Research Lab: Matt Mulvey's Lab

Division: Cell Biology & Immunology

Supporting Staff:   Mark Malcolm, M.S.  

 

About Matt Mulvey, Ph.D.

My lab is interested in understanding the mechanisms and consequences of bacterial interactions with host cells and tissues.  Contact between a bacterial pathogen and its host is often mediated by microbial adhesive molecules known as adhesins and specific host cell receptors. Bacterial attachment to host receptors can initiate a cascade of molecular crosstalk between bacterial and host cells that can directly influence the outcome of an infection. Examination of the pathogenesis of urinary tract infections (UTIs) provides an excellent system to delineate host-pathogen interactions at the molecular, cellular, and tissue levels. UTIs affect a large proportion of the world population and account for significant morbidity and high medical costs.  Strains of uropathogenic Escherichia coli (UPEC) are the primary causative agents of UTIs.  In addition to UTIs, UPEC-related isolates, collectively known as extra-intestinal pathogenic E. coli (ExPEC), are responsible for a variety of other infections, including pneumonia, bacteremia, neonatal meningitis, deep surgical wound infections, and vertebral osteomyelitis.  Within the urinary tract, UPEC isolates are able to bind and invade host epithelial cells. Once internalized, UPEC can either multiply or enter a quiescent, non-replicating state.  Host stress and inflammatory response pathways along with host cytoskeletal components and virulence factors encoded by the pathogen all likely modulate intracellular growth and the eventual efflux of UPEC.  Infection by UPEC stimulates a slew of anti-microbial, pro-inflammatory, pro-differentiation and host cell suicide pathways within the urinary tract. These host responses, in turn, can result in activation of stress response pathways and virulence gene expression in UPEC.  Using genetics, microscopy, biochemistry, global gene expression analysis and molecular biology techniques coupled with cell culture,  tissue, mouse and zebra fish model systems, we are working to identify and characterize host and bacterial factors that allow UPEC and other pathogens to colonize and persist within host tissues.  Specific research aims in the lab include:

1. Defining the mechanisms by which UPEC invades, traffics, multiplies, and persists within host epithelial cells.

2.  Defining how ExPEC responds to and resists nitrosative and oxidative stress encountered during the course of an infection.

3.  Determining how ExPEC modulates host cell death and survival pathways.


Selected Publications

  • Eto DS, Jones TA, Sunbdsbak JL and Mulvey MA (2007). Integrin-mediated invasion of host cells by type 1-piliated uropathogenic Escherichia coli. PLoS Pathogens, in press.
  • Eto DS, Sundsbak JL, and Mulvey MA (2006). Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell. Microbiol. 8(4):704-17.
  • Bower JM and Mulvey MA (2006). Polyamine-mediated resistance of uropathogenic Escherichia coli to nitrosative stress. J. Bacteriol. 2006, 188(3):928-933.
  • Mulvey MA*, Schilling JD*, and Hultgren SJ (2001). Establishment of a persistent E. coli reservoir during the acute phase of a bladder infection. Infect. Immun., 69:4572-4579. Equal contributors to this paper.
  • All Publications: Click Here

Professional Education

  • Baccalaureate Degree: B.S., 1990, University of Texas at Austin, Biological Sciences (Molecular Biology).
  • Advanced Degree: Ph.D., December, 1995, University of Texas at Austin, Biological Sciences (Virology).
  • Postdoctoral Fellowships:12/95 – 09/1996: Biomedical Centre, Uppsala, Sweden.
  • 09/96 – 01/2001: Washington University School of Medicine, St. Louis, Department of Molecular Microbiology.